Literature DB >> 21832541

A facile nanoaggregation strategy for oral delivery of hydrophobic drugs by utilizing acid-base neutralization reactions.

Huabing Chen1, Jiangling Wan, Yirui Wang, Dongsheng Mou, Hongbin Liu, Huibi Xu, Xiangliang Yang.   

Abstract

Nanonization strategies have been used to enhance the oral availability of numerous drugs that are poorly soluble in water. Exploring a facile nanonization strategy with highly practical potential is an attractive focus. Here, we report a novel facile nanoaggregation strategy for constructing drug nanoparticles of poorly soluble drugs with pH-dependent solubility by utilizing acid-base neutralization in aqueous solution, thus facilitating the exploration of nanonization in oral delivery for general applicability. We demonstrate that hydrophobic itraconazole dissolved in acid solution formed a growing core and aggregated into nanoparticles in the presence of stabilizers. The nanoparticles, with an average diameter of 279.3 nm and polydispersity index of 0.116, showed a higher dissolution rate when compared with the marketed formulation; the average dissolution was about 91.3%. The in vivo pharmacokinetic studies revealed that the nanoparticles had a rapid absorption and enhanced oral availability. The diet state also showed insignificant impact on the absorption of itraconazole from nanoparticles. This nanoaggregation strategy is a promising nanonization method with a facile process and avoidance of toxic organic solvents for oral delivery of poorly soluble drugs with pH-dependent solubility and reveals a highly practical potential in the pharmaceutical and chemical industries.

Entities:  

Year:  2008        PMID: 21832541     DOI: 10.1088/0957-4484/19/37/375104

Source DB:  PubMed          Journal:  Nanotechnology        ISSN: 0957-4484            Impact factor:   3.874


  4 in total

1.  Dissolution improvement of electrospun nanofiber-based solid dispersions for acetaminophen.

Authors:  Deng-Guang Yu; Christopher Branford-White; Kenneth White; Xue-Lian Li; Li-Min Zhu
Journal:  AAPS PharmSciTech       Date:  2010-05-06       Impact factor: 3.246

2.  Elucidating the in vivo fate of nanocrystals using a physiologically based pharmacokinetic model: a case study with the anticancer agent SNX-2112.

Authors:  Dong Dong; Xiao Wang; Huailing Wang; Xingwang Zhang; Yifei Wang; Baojian Wu
Journal:  Int J Nanomedicine       Date:  2015-03-31

3.  A novel albumin wrapped nanosuspension of meloxicam to improve inflammation-targeting effects.

Authors:  Qi Li; Fen Chen; Yun Liu; Shihui Yu; Xiumei Gai; Mingzhu Ye; Xinggang Yang; Weisan Pan
Journal:  Int J Nanomedicine       Date:  2018-08-15

4.  Enhanced transdermal delivery of meloxicam by nanocrystals: Preparation, in vitro and in vivo evaluation.

Authors:  Qin Yu; Xiying Wu; Quangang Zhu; Wei Wu; Zhongjian Chen; Ye Li; Yi Lu
Journal:  Asian J Pharm Sci       Date:  2017-12-07       Impact factor: 6.598

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.